Antonella Morea

Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience

M. Megna, I. Simone, F. Puntillo, 2021, Clinical Drug Investigation.

King's college progression rate at first clinical evaluation: A new measure of disease progression in amyotrophic lateral sclerosis

I. Simone, S. Zoccolella, A. Fraddosio, 2021, Journal of the Neurological Sciences.

Inclusion of motor evoked abnormalities in amyotrophic lateral sclerosis: a diagnostic algorithm to early classify lower motor neuron phenotypes

I. Simone, S. Zoccolella, A. Scarafino, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Eyelid myoclonia with absences, intellectual disability and attention deficit hyperactivity disorder: a clinical phenotype of the RORB gene mutation

T. Francavilla, A. La Neve, G. Boero, 2021, Neurological Sciences.

Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis

I. Simone, A. Scarafino, M. Mastrapasqua, 2018, Journal of Neurology.

Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype

I. Simone, S. Zoccolella, A. Scarafino, 2020, Journal of Neurology.